In summary, these examples highlight the impacts of CIC‐KO and IDH1‐R132H on enhancers at genes associated with CNS tumours and, regarding NFIA, illustrate an interesting case of an enhancer whose activity is differentially regulated by CIC loss in an IDH1‐dependent fashion. Here, IDH1 is linked to central nervous system neoplasm.